SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-057889
Filing Date
2023-12-15
Accepted
2023-12-15 16:21:41
Documents
12
Period of Report
2023-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ef20016739_8k.htm   iXBRL 8-K 28512
  Complete submission text file 0001140361-23-057889.txt   166700

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gyre-20231211.xsd EX-101.SCH 3907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gyre-20231211_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gyre-20231211_pre.xml EX-101.PRE 16072
6 EXTRACTED XBRL INSTANCE DOCUMENT ef20016739_8k_htm.xml XML 4205
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 231490653
SIC: 2834 Pharmaceutical Preparations